The Biotech Growth Trust
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of The Biotech Growth Trust generated cash of -$4,241,000, which is more than the previous year. Cash used in financing activities reached the amount of -$18,741,000 last year. Net change in cash is therefore -$641,000.
Cash Flow
| 2012 | -439K | 0 | -5.20M |
|---|---|---|---|
| 2016 | -5.90M | 43.88M | -25.78M |
| 2018 | -4.10M | -7.80M | 24.99M |
| 2020 | -3.76M | 90.93M | -87.16M |
| 2021 | -5.67M | -25.54M | 32.72M |
| 2023 | -5.89M | 45.69M | -37.03M |
| 2024 | -4.24M | 22.34M | -18.74M |
BIOG.L Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.77M | 0 | 0 | 0 | -13.08M | -48.38M | 5.69M |
Operating activities | |||||||
Net income | 74.6M | -41.24M | 200.55M | 61.09M | -29.54M | -128.69M | 40.51M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -6K | 28K | 3K | -17K | 96K | -24K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -4.24M | -5.89M | -5.67M | -3.76M | -4.10M | -5.90M | -439K |
Investing activities | |||||||
Purchases Of Investments | -350.83M | -459.60M | -599.97M | -491.47M | -293.18M | -378.90M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 22.34M | 45.69M | -25.54M | 90.93M | -7.80M | 43.88M | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 35.53M | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -43.91M | -20.91M | 0 | -106.07M | 0 | -25.78M | -5.20M |
Repayments of term debt | 26.28M | -15.33M | -2.56M | 18.91M | 24.99M | 0 | 0 |
Cash used in financing activities | -18.74M | -37.03M | 32.72M | -87.16M | 24.99M | -25.78M | -5.20M |
Net Change In Cash | -641K | 2.77M | 1.50M | 0 | 13.08M | 12.19M | -5.87M |
Cash at end of period | 2.13M | 2.77M | 1.50M | 0 | 0 | -36.18M | -182K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |